Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Earnings Preview — 6741 total
XMTR carries a put/call ratio four standard deviations above its 20-day average into Tuesday's Q3 results, making it one of the most unusual options setups in its recent history. The options market is flashing its most…
An activist investor holding nearly 10% of MDA Space is the most consequential fact heading into Wednesday's earnings release, arriving as the stock trades at its weakest level in months. MARISELLE A.S. filed a…
VAL fell 10% on Monday to $94.69, a sharper single-day move than any of its closest peers. RIG dropped 10.2% on the same session, while NE fell 7.2% and SDRL lost 9.2%. The week's pattern tells a similar story: VAL is…
Recursion Pharmaceuticals enters today's earnings with a short position that dwarfs most of its closest peers. Short interest runs at 31.5% of free float, roughly 162 million shares, while correlated names like CRSP…
ABNB reports Q3 results on Thursday with options traders staking out the most defensive position seen all year, even as short sellers quietly cover and borrow remains essentially free. The options signal is the…
Among California Resources Corporation's closest energy peers, short positioning looks considerably more aggressive at several names. CRC carries 5.2% of its free float sold short, a meaningful but not extreme level…
GoodRx Holdings reports Q3 results on November 4, trading at $3.55 after a quiet month that saw shares gain just over 8% while short sellers retreated sharply from the stock. The retreat in short interest is the…
Kymera Therapeutics goes into its November 5 results with the stock up 11% in a single week, a wave of analyst target increases still landing, and options positioning that has turned noticeably more call-heavy, an…
People Incorporated is better shielded than most of its peer group right now, but that relative calm sits on top of a short book that has rarely been larger. Among its closest correlated names, short pressure is more…
Adeia Inc. heads into its November 5 earnings report with short sellers quietly stepping back even as the stock has shed a fifth of its value over the past month. The short-selling picture has turned notably less…
Nearly one in five LYFT shares outstanding is sold short, yet options traders shifted sharply toward calls last week, a split that makes Thursday's Q3 report more consequential than most. Short interest has held above…
Fox Corporation reports first-quarter fiscal 2027 results on November 4, carrying an unusually large short position and a sharp shift in options sentiment into the print. Short interest has stabilised near 24.1% of the…
Keurig Dr Pepper reports Q3 results today, November 3, against a backdrop that is unusually split: options traders are the most bullish they have been all year, while short sellers have sharply rebuilt positions over…
Inspire Medical Systems heads into its November 3 earnings report with short sellers sitting at their most aggressive position in months, even as the borrow market remains wide open. Short interest has climbed to…
HLMN heads into its Q3 earnings report today carrying its sharpest weekly rally in months, making the print a direct test of whether the recent run has fundamental backing. The stock has climbed 16% over the past week…
ROKU closed at $155.52 on Monday, down 1.1% on the week against a median gain of 1.0% for its closest peers. Short interest pulled back sharply on October 30, dropping 7% in a single session to 10.3 million shares, or…
MTCH closed at $42.07 on Monday, down nearly 7% on the week, yet the options market is sending an unusually optimistic signal into tonight's earnings release. The put/call ratio dropped to 0.52 on Monday, almost three…
ICHR heads into its Q3 earnings report with the stock deep in freefall, down 41% over the past month and testing ground not seen in this cycle's recovery. The most striking feature of the setup is how little the…
IIPR enters today's earnings report having shed short interest at a pace far outside its own historical range. Short positions dropped nearly 17% over the past week, a move 3.5 standard deviations below the company's…
Bioventus heads into today's Q3 results with short sellers trimming exposure even as the stock pulls back sharply from its 2026 highs. The clearest signal in the positioning data is the retreat of short sellers. Short…
